Doxorubicin plus trabectedin for metastatic or unresectable leiomyosarcoma
Year: 2022
Type: letter
Source: The Lancet Oncology
Institution: Gazi University
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4297103012
